These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 3600616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M, Waelbroeck M, Christophe J.
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [Abstract] [Full Text] [Related]

  • 3. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
    Waelbroeck M, Gillard M, Robberecht P, Christophe J.
    Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
    [Abstract] [Full Text] [Related]

  • 4. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J, Marquez E, Laukkonen S, Martos F, Gómez A, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [Abstract] [Full Text] [Related]

  • 7. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB, Eubanks JH, Creese I.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [Abstract] [Full Text] [Related]

  • 8. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [Abstract] [Full Text] [Related]

  • 10. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [Abstract] [Full Text] [Related]

  • 11. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S, Musílková J, Nedoma J, Proska J, Shelkovnikov S, Vorlícek J.
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [Abstract] [Full Text] [Related]

  • 12. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Buckley NJ, Bonner TI, Buckley CM, Brann MR.
    Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
    [Abstract] [Full Text] [Related]

  • 13. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [Abstract] [Full Text] [Related]

  • 14. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
    Gillard M, Waelbroeck M, Christophe J.
    J Recept Res; 1986 May; 6(1):47-61. PubMed ID: 3754901
    [Abstract] [Full Text] [Related]

  • 15. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE, Michel AD, Whiting RL.
    Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
    [Abstract] [Full Text] [Related]

  • 16. Muscarinic M1 and M3 receptors in rat striatum: a binding study.
    de la Vega MT, Nuñez A, Arias-Montaño JA.
    Arch Med Res; 1997 Feb; 28(4):493-7. PubMed ID: 9428572
    [Abstract] [Full Text] [Related]

  • 17. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S, Buckley NJ, Roberts FF.
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [Abstract] [Full Text] [Related]

  • 18. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
    Ehlert FJ, Delen FM, Yun SH, Friedman DJ, Self DW.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
    [Abstract] [Full Text] [Related]

  • 19. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G, Waelbroeck M, Mash DC, Flynn DD.
    Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
    [Abstract] [Full Text] [Related]

  • 20. Evidence of paired M2 muscarinic receptors.
    Potter LT, Ballesteros LA, Bichajian LH, Ferrendelli CA, Fisher A, Hanchett HE, Zhang R.
    Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.